The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
The Effect of Common Polymorphisms of the β2-Adrenergic Receptor on Agonist-Mediated Vascular Desensitization
Abstract
BACKGROUND: With continuous exposure to beta2-adrenergic agonists, vascular tissue becomes desensitized to agonist-mediated vasodilatation. We studied the effects of two common polymorphisms of the beta2-adrenergic receptor, one at codon 16 and one at codon 27, on agonist-mediated vasodilatation and desensitization in the vascular bed. METHODS: We studied 26 healthy subjects who were selected to represent three genotypes: 7 were homozygous for the alleles encoding Arg16 and Gln27, 8 were homozygous for the alleles encoding Gly16 and Gln27, and 11 were homozygous for the alleles encoding Gly16 and Glu27. Vascular responses were assessed by measuring changes in the diameter of a dorsal hand vein. A dose-response curve of the effect of the beta2-adrenergic-receptor agonist isoproterenol was constructed (dose range, 4 to 480 ng per minute). Desensitization was then induced by a 2-hour continuous infusion of isoproterenol, and venodilatation was measured 30, 60, 90, and 120 minutes after the start of the infusion. RESULTS: Subjects who were homozygous for Arg16 had almost complete desensitization; venodilatation in response to isoproterenol in this group decreased from a mean (+/-SE) of 44+/-11 percent to 8+/-4 percent (P=0.006). In contrast, subjects who were homozygous for Gly16 did not have significant desensitization, irrespective of the amino acid encoded by codon 27. Subjects who were homozygous for Glu27 had higher maximal venodilatation in response to isoproterenol than those who were homozygous for Gln27 (86+/-13 percent vs. 54+/-8 percent, P=0.03). CONCLUSIONS: The Arg16 polymorphism of the beta2-adrenergic receptor is associated with enhanced agonist-mediated desensitization in the vasculature, and the Glu27 polymorphism is associated with increased agonist-mediated responsiveness. Therefore, polymorphisms of the beta2-adrenergic receptor are potentially important determinants of the vascular response to stress.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440420033005 · Cited by 3,777
Burt, V. L., Whelton, P., Roccella, E. J., Brown, C., Cutler, J. A., Higgins, M., Horan, M. J., & Labarthe, D. (1995) · Hypertension · doi:10.1161/01.hyp.25.3.305 · Cited by 2,998
Drysdale, C. M., McGraw, D. W., Stack, C. B., Stephens, J. C., Judson, R. S., Nandabalan, K., Arnold, K., Ruano, G., & Liggett, S. B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.19.10483 · Cited by 964
Mutations in the Gene Encoding for the β 2 -adrenergic Receptor in Normal and Asthmatic Subjects
Reihsaus, E., Innis, M., MacIntyre, N., & Liggett, S. B. (1993) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/8.3.334 · Cited by 617
Plasma catecholamines and essential hypertension. An analytical review.
Goldstein, D. S. (1983) · Hypertension · doi:10.1161/01.hyp.5.1.86 · Cited by 600
Preeclampsia — A State of Sympathetic Overactivity
Schobel, H. P., Fischer, T., Heuszer, K., Geiger, H., & Schmieder, R. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199611143352002 · Cited by 555
ISRAEL, E., DRAZEN, J. M., LIGGETT, S. B., BOUSHEY, H. A., CHERNIACK, R. M., CHINCHILLI, V. M., COOPER, D. M., FAHY, J. V., FISH, J. E., FORD, J. G., et al. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.1.9907092 · Cited by 549
Green, S. A., Cole, G., Jacinto, M., Innis, M., & Liggett, S. B. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49434-9 · Cited by 457
Green, S. A., Turki, J., Bejarano, P., Hall, I. P., & Liggett, S. B. (1995) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.13.1.7598936 · Cited by 439
Bristow, M. R., Hershberger, R. E., Port, J. D., Minobe, W., & Rasmussen, R. (1989) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11117-6 · Cited by 381
Cited by
Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects
Evans, W. E., & McLeod, H. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020526 · Cited by 1,769
Pharmacogenomics and Individualized Drug Therapy
Eichelbaum, M., Ingelman-Sundberg, M., & Evans, W. E. (2006) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104724 · Cited by 720
Pharmacogenetics, Pharmacogenomics, and Individualized Medicine
Ma, Q., & Lu, A. Y. H. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003533 · Cited by 464
Nabel, E. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmra035098 · Cited by 431
Schwartz, A. R., Gerin, W., Davidson, K. W., Pickering, T. G., Brosschot, J. F., Thayer, J. F., Christenfeld, N., & Linden, W. (2003) · Psychosomatic Medicine · doi:10.1097/01.psy.0000046075.79922.61 · Cited by 383
Metadata
- Authors
- Dishy, V., Sofowora, G. G., Xie, H.-G., Kim, R. B., Byrne, D. W., Stein, C. M., & Wood, A. J. J.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2001-10-04
- Volume
- 345
- Issue
- 14
- Pages
- 1030-1035
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1970283298
- Cited by
- 363
- References
- 25
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effect of Common Polymorphisms of the β2-Adrenergic Receptor on Agonist-Mediated Vascular Desensitization. https://app.cochat.ai/papers/10.1056/nejmoa010819
- The paper
- Dishy, V., Sofowora, G. G., Xie, H.-G., Kim, R. B., Byrne, D. W., Stein, C. M., & Wood, A. J. J. (2001). The Effect of Common Polymorphisms of the β2-Adrenergic Receptor on Agonist-Mediated Vascular Desensitization. New England Journal of Medicine. https://doi.org/10.1056/nejmoa010819
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.